M140
Methylcarbamylcholine chloride
solid, ≥97% (NMR)
Synonym(s):
Methylcarbachol
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(CH3)3N+CH2CH2OC(O)NHCH3 Cl-
CAS Number:
Molecular Weight:
196.68
UNSPSC Code:
12352200
MDL number:
assay
≥97% (NMR)
form
solid
storage condition
desiccated
color
white
solubility
H2O: soluble, methanol: soluble
Gene Information
Biochem/physiol Actions
Studies of correlation between receptor changes and behavioral function as result of chronic administration of the nicotinic agonist, methylcarbamylcholine (MCC) or the competitive antagonist dihydro-beta-erythroidine (DHBE) in rats shown that the treatment reversibly increased the apparent Bmax and Kd of cortical nAChRs in a dose- and time-dependent manner. DHBE pretreatment inhibited the MCC-induced behavioral changes. The time course of the development of tolerance to MCC as well as the extent of inhibition of DHBE were well correlated with the time course for receptor up-regulation and inhibition of the increase in binding parameters, respectively. Like chronic MCC treatment, chronic DHBE increased the number of [3H]cytisine binding sites but without concomitant development of behavioral tolerance. DHBE pretreatment inhibited the MCC-induced behavioral changes.
Disclaimer
Hygroscopic
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
X Yang et al.
The Journal of pharmacology and experimental therapeutics, 271(2), 651-659 (1994-11-01)
Chronic administration of nicotine results in increased numbers of specific nicotinic acetylcholine receptors (nAChRs) within the central nervous system. The purpose of this study was to determine: 1) whether chronic administration of the nicotinic agonist, methylcarbamylcholine (MCC) or the competitive
D M Araujo et al.
Journal of neurochemistry, 51(1), 292-299 (1988-07-01)
The present experiments show that N-[3H]-methylcarbamylcholine ([3H]MCC) binds specifically and with high affinity to rat hippocampus, frontal cortex, and striatum. The highest maximal density of binding sites was apparent in frontal cortex and the lowest in hippocampus. [3H]MCC binding was
S J Lansdell et al.
Neuropharmacology, 39(4), 671-679 (2000-03-23)
A series of cell lines stably expressing recombinant nicotinic acetylcholine receptors (nAChRs) has been established by transfection of mammalian (rat) and insect (Drosophila) nicotinic subunit cDNAs. By equilibrium radioligand binding, we have examined the influence of individual subunits upon the
P A Lapchak et al.
Journal of neurochemistry, 52(2), 483-491 (1989-02-01)
It has been reported that N-methylcarbamylcholine (MCC), a nicotinic agonist, binds to central nicotinic receptors and causes an increase of acetylcholine (ACh) release from certain central cholinergic nerve terminals. The present experiments determine whether these two phenomena change in response
Related Content
Bath Salts in Urine - Supel-Select SCX SPE and Ascentis Express HILIC Application Note
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service